Portola Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PORTOLA PHARMS INC, and when can generic versions of PORTOLA PHARMS INC drugs launch?
PORTOLA PHARMS INC has one approved drug.
There are five US patents protecting PORTOLA PHARMS INC drugs.
There are sixty-three patent family members on PORTOLA PHARMS INC drugs in twenty-six countries.
Summary for Portola Pharms Inc
International Patents: | 63 |
US Patents: | 5 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Portola Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | DISCN | Yes | No | 8,557,852 | ⤷ Sign Up | ⤷ Sign Up | ||||
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | DISCN | Yes | No | 8,987,463 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | DISCN | Yes | No | 8,404,724 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | DISCN | Yes | No | 8,404,724 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | DISCN | Yes | No | 8,987,463 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | DISCN | Yes | No | 9,555,023 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Portola Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | 9,629,831 | ⤷ Sign Up |
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | 8,691,847 | ⤷ Sign Up |
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | 6,376,515 | ⤷ Sign Up |
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | 6,376,515 | ⤷ Sign Up |
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | 8,518,977 | ⤷ Sign Up |
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | 8,691,847 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Portola Pharms Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 1948608 | ⤷ Sign Up |
European Patent Office | 2431358 | ⤷ Sign Up |
Taiwan | 200736221 | ⤷ Sign Up |
South Africa | 200803820 | ⤷ Sign Up |
Japan | 5662980 | ⤷ Sign Up |
Canada | 2671502 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.